OTC · Medical - Specialties

Genex Pharmaceutical, Inc. (GENX) Stock

$0.00 OTC: GENX Healthcare

Genex Pharmaceutical, Inc. engages in the development and production of Reconstituted Bone Xenograft, which is a medical device that accelerates bone healing.

Valuation

MetricValue
Price$0.00
Market Cap$1788
P/E Ratio0.01
P/B Ratio0.00
P/S Ratio0.00
EPS (TTM)$0.02
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE0.00%
ROA3.96%
ROCE9.01%
Gross Margin0.00%
Operating Margin14.40%
Net Margin10.58%
Debt/Equity0.00
Current Ratio0.67

Annual Financials (USD)

Metric20032004200520062007
Revenue$0$2.0M$2.0M$2.0M$3.0M
Operating Profit$0$1.0M$1.0M$1.0M$0
Net Profit$0$1.0M$1.0M$1.0M$0
EPS$0.00$0.06$0.04$0.03$0.02
Op Margin1500.3%42.2%37.0%34.7%14.4%

Balance Sheet (USD)

Metric20032004200520062007
Total Assets$0$3.0M$4.0M$6.0M$9.0M
Total Liabilities$0$0$1.0M$2.0M$4.0M
Cash$0$0$0$0$0
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20032004200520062007
Operating Cash Flow$0$0$1.0M$1.0M$1.0M
Investing Cash Flow$0$0$0$-1.0M$-2.0M
Financing Cash Flow$0$0$0$0$2.0M
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$0$1.0M$1.0M$1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.54
FCF Yield29552.85%
Quick Ratio0.48
Interest Coverage0.00
Return 1Y0.00%
Return 3Y0.00%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CBGIThe CannaBusiness Group, Inc. $0.00 — 0.00 $1831 0.00%
FIORFFiore Cannabis Ltd. $0.00 — 0.00 $1971 0.00%
GGBXFGreen Growth Brands Inc. $0.00 — 0.00 $2061 0.00%
JUVAFJuva Life Inc. $0.00 — 0.00 $1641 0.00%
LTHOLegacy Technology Holdings, Inc. $0.00 — -0.18 $1720 0.00%

About Genex Pharmaceutical, Inc.

Genex Pharmaceutical, Inc. engages in the development and production of Reconstituted Bone Xenograft, which is a medical device that accelerates bone healing. The company was founded on February 28, 2002 and is headquartered in Tianjin, China.

Genex Pharmaceutical, Inc. (GENX) stock trades at $0.00 with a market capitalization of $1788. The stock is valued at a price-to-earnings (P/E) ratio of 0.01, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Genex Pharmaceutical, Inc. generates a return on equity (ROE) of 0.00%, return on capital employed of 9.01%, an operating margin of 14.40%, a net profit margin of 10.58%.

Official website: www.genprex.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides